Adamas provides preliminary fourth quarter and full year 2020 total revenues and key business drivers for 2021

-- total revenues expected to be $20.8 million for fourth quarter 2020 and $74.2 million for full year 2020 -- -- product sales of gocovri® expected to be $19.8 million for fourth quarter 2020 and $71.2 million for full year 2020 --

ADMS Ratings Summary

ADMS Quant Ranking